In Bleeding Haemaprot 1.4mg Infusion helps control excessive bleeding in various conditions such as surgeries, heavy bleeding during periods, nosebleeds etc. It prevents damage to clots, enhances clot formation and helps prevent complications of excessive bleeding such as hemorrhage. It is given as an injection by a doctor or nurse and should not be self-administered.
It is not known whether it is safe to consume alcohol with Haemaprot 1.4mg Infusion. Please consult your doctor.
Haemaprot 1.4mg Infusion is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Haemaprot 1.4mg Infusion is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Not relevant, as Haemaprot 1.4mg Infusion is intended for use in hospitalised patients.
Haemaprot 1.4mg Infusion is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Haemaprot 1.4mg Infusion may not be needed in these patients. Please consult your doctor.
There is limited information available on the use of Haemaprot 1.4mg Infusion in patients with liver disease. Please consult your doctor.
If you miss a dose of Haemaprot 1.4mg Infusion, skip it and continue with your normal schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More